Show simple item record

dc.contributor.authorLynch, TR
dc.contributor.authorHempel, RJ
dc.contributor.authorWhalley, B
dc.contributor.authorByford, S
dc.contributor.authorChamba, R
dc.contributor.authorClarke, P
dc.contributor.authorClarke, S
dc.contributor.authorKingdon, DG
dc.contributor.authorO'Mahen, H
dc.contributor.authorRemington, B
dc.contributor.authorRushbrook, SC
dc.contributor.authorShearer, J
dc.contributor.authorStanton, M
dc.contributor.authorSwales, M
dc.contributor.authorWatkins, A
dc.contributor.authorRussell, IT
dc.date.accessioned2020-01-17T15:07:54Z
dc.date.issued2019-07-18
dc.description.abstractBACKGROUND: Individuals with depression often do not respond to medication or psychotherapy. Radically open dialectical behaviour therapy (RO DBT) is a new treatment targeting overcontrolled personality, common in refractory depression.AimsTo compare RO DBT plus treatment as usual (TAU) for refractory depression with TAU alone (trial registration: ISRCTN 85784627). METHOD: RO DBT comprised 29 therapy sessions and 27 skills classes over 6 months. Our completed randomised trial evaluated RO DBT for refractory depression over 18 months in three British secondary care centres. Of 250 adult participants, we randomised 162 (65%) to RO DBT. The primary outcome was the Hamilton Rating Scale for Depression (HRSD), assessed masked and analysed by treatment allocated. RESULTS: After 7 months, immediately following therapy, RO DBT had significantly reduced depressive symptoms by 5.40 points on the HRSD relative to TAU (95% CI 0.94-9.85). After 12 months (primary end-point), the difference of 2.15 points on the HRSD in favour of RO DBT was not significant (95% CI -2.28 to 6.59); nor was that of 1.69 points on the HRSD at 18 months (95% CI -2.84 to 6.22). Throughout RO DBT participants reported significantly better psychological flexibility and emotional coping than controls. However, they reported eight possible serious adverse reactions compared with none in the control group. CONCLUSIONS: The RO DBT group reported significantly lower HRSD scores than the control group after 7 months, but not thereafter. The imbalance in serious adverse reactions was probably because of the controls' limited opportunities to report these.Declaration of interestSix of the 16 authors have received royalties or fees for RO DBT. R.J.H. is co-owner and director of Radically Open Ltd, the RO DBT training and dissemination company. D.K. reports grants outside the submitted work from NIHR. T.R.L. receives royalties from New Harbinger Publishing for sales of RO DBT treatment manuals, speaking fees from Radically Open Ltd and a grant outside the submitted work from the Medical Research Council. He was codirector of Radically Open Ltd between November 2014 and May 2015 and is married to Erica Smith-Lynch, the principal shareholder and one of two current directors of Radically Open Ltd. H.O'M. reports personal fees from the Charlie Waller Institute and Improving Access to Psychological Therapy. S.C.R. provides RO DBT supervision through S C Rushbrook Ltd. I.T.R. reports grants outside the submitted work from NIHR and Health & Care Research Wales. M.St. reports personal fees from British Isles DBT Training, Stanton Psychological Services Ltd, and Taylor & Francis Ltd. M.Sw. reports personal fees from British Isles DBT Training, Guilford Press, Oxford University Press and Taylor & Francis Ltd. B.W. was codirector of Radically Open Ltd between November 2014 and February 2015.en_GB
dc.description.sponsorshipEfficacy and Mechanism Evaluation (EME) Programmeen_GB
dc.identifier.citationPublished online 18 July 2019en_GB
dc.identifier.doi10.1192/bjp.2019.53
dc.identifier.grantnumber09/150/12en_GB
dc.identifier.urihttp://hdl.handle.net/10871/40477
dc.language.isoenen_GB
dc.publisherCambridge University Press (CUP) / Royal College of Psychiatristsen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/31317843en_GB
dc.relation.urlhttps://zenodo.org/record/1442883en_GB
dc.rights© The Royal College of Psychiatrists 2019. This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.en_GB
dc.subjectTreatment-resistant depressionen_GB
dc.subjectchronic depressionen_GB
dc.subjectpersonality disorderen_GB
dc.subjectradically open dialectical behaviour therapy (RO DBT)en_GB
dc.subjectrandomised controlled trialen_GB
dc.titleRefractory depression - mechanisms and efficacy of radically open dialectical behaviour therapy (RefraMED): findings of a randomised trial on benefits and harmsen_GB
dc.typeArticleen_GB
dc.date.available2020-01-17T15:07:54Z
exeter.place-of-publicationEnglanden_GB
dc.descriptionThis is the final version. Available on open access from Cambridge University Press via the DOI in this recorden_GB
dc.descriptionData availability: All non-confidential data and syntax for analyses reported here are available online (https://zenodo.org/record/1442883).en_GB
dc.identifier.eissn1472-1465
dc.identifier.journalBritish Journal of Psychiatryen_GB
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2019-02-15
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2019-07-18
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2020-01-17T15:04:13Z
refterms.versionFCDVoR
refterms.dateFOA2020-01-17T15:07:58Z
refterms.panelAen_GB
refterms.depositExceptionpublishedGoldOA


Files in this item

This item appears in the following Collection(s)

Show simple item record

© The Royal College of Psychiatrists 2019.
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Except where otherwise noted, this item's licence is described as © The Royal College of Psychiatrists 2019. This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.